Joyce He

发表

Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL.

J. Friedberg, B. Cheson, S. O'brien, 2016, Blood.

Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1)

J. Ajani, M. Shah, G. Bodoky, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.